Suchergebnisse - "van de Donk, Niels W C J"

PubPharm (215)

41

Detection and localization of early- and late-stage cancers using platelet RNA

enthalten in: Cancer cell | 2022

von In 't Veld, S. | Arkani, M. | Post, E. | +98

CommentIn: Clin Chem Lab Med. 2022 Dec 02;61(6):e85-e86. - PMID 36472964

42

Teclistamab in Relapsed or Refractory Multiple Myeloma

enthalten in: The New England journal of medicine | 2022

von Moreau, P. | Garfall, A. | van de Donk, N. | +31

CommentIn: N Engl J Med. 2022 Aug 11;387(6):558-561. - PMID 35947712

43

Treatment emergent peripheral neuropathy in the CASSIOPEIA trial

enthalten in: Haematologica | 2022

von Fokkema, C. | Moreau, P. | Van der Holt, B. | +17

44

LocoMMotion : a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

enthalten in: Leukemia | 2022

von Mateos, M. | Weisel, K. | De Stefano, V. | +30

45

Waldenström macroglobulinemia presenting as nephrotic syndrome : Renal heavy and light chain amyloidosis

enthalten in: EJHaem | 2022

von Kwakernaak, A. | Bernelot Moens, S. | Hilhorst, M. | +3

46

Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas

enthalten in: Cancer research communications | 2022

von Martens, A. | Rietveld, J. | de Boer, R. | +12

47

High-dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma

enthalten in: British journal of haematology | 2022

von Aydin, M. | Tang, M. | Wondergem, M. | +7

48

Increased mortality risk in multiple-myeloma patients with subsequent malignancies : a population-based study in the Netherlands

enthalten in: Blood cancer journal | 2022

von Brink, M. | Minnema, M. | Visser, O. | +12

49

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

enthalten in: Blood cancer journal | 2022

von Cohen, A. | Parekh, S. | Santomasso, B. | +22

50

Prognostic value of minimal residual disease negativity in myeloma : combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA

enthalten in: Blood | 2022

von Cavo, M. | San-Miguel, J. | Usmani, S. | +24

CommentIn: Blood. 2022 Feb 10;139(6):799-802. - PMID 35142848